BN Business News
Add your company to Business Communicator →

Business · 27/07/1995Updated: 10/18/2026 · 1 min read

FDA Proposes Amendment to OTC Bronchodilator Drug Products to Remove Ephedrine Ingredients

Summary

The FDA is proposing to amend the monograph for OTC bronchodilator drug products to remove ephedrine and its derivatives due to concerns over their misuse and potential harm, in response to a request from the DEA and comments from advisory committees.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →